Specimens
Structures cataloged on encounter. Each entry is a permanent record of what the Voyager observed and what HOUSTON enriched.
Cataloged
8 structures
Deck Bio
Cambridge, MA, USATCR-based therapeutics targeting intracellular cancer antigens on solid tumors
PreclinicalPrivateUS-BasedPreclinical
Ternary Therapeutics
AI-driven platform developing molecular glue therapeutics for undruggable targets in immunology
PreclinicalPrivateEurope-BasedPreclinical
Stipple Bio
Epitope resolution platform discovering novel cancer targets for multiple therapeutic modalities
PreclinicalPrivateUS-BasedPreclinical
TRIANA Biomedicines
Waltham, Massachusetts, United StatesDevelops molecular glue therapeutics for targeted protein degradation in cancer
ClinicalPrivateUS-BasedClinical-Stage
Commit Biologics
Aarhus, Midtjylland, DenmarkDevelops bispecific antibodies targeting complement system for cancer and autoimmune diseases
PreclinicalPrivateEurope-BasedPreclinical
Neutrolis
Cambridge, MA, United StatesDevelops DNASE1L3-based enzyme therapies targeting NETs in autoimmune disease
ClinicalPrivateUS-BasedClinical-Stage
AvenCell Therapeutics
Developing switchable allogeneic CAR-T platform for hematological cancers and autoimmune diseases
ClinicalPrivateUS-BasedClinical-Stage
Alltrna
Cambridge, Massachusetts, United StatesDevelops tRNA therapeutics to restore protein function in genetic diseases
ClinicalPrivateUS-BasedClinical-Stage